MedTrace Logo

Short- and Long Term Growth in Children With Asthma

NCT00380484 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2008-02-27

No results posted yet for this study

Summary

The purpose of this study is to assess if treatment with budesonide 200 microgram per day affects short- or long term growth in children with asthma

Conditions

Interventions

DRUG

Budesonide

200µg daily

DRUG

Montelukast

5 mg daily

Sponsors & Collaborators

  • Children´s Clinic, Randers

    lead OTHER

Principal Investigators

  • Ole D Wolthers · Children's Clinic Randers

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2008-02-29
Completion
2008-02-29

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00380484 on ClinicalTrials.gov